التفاصيل البيبلوغرافية
| العنوان: |
Serum biomarkers in patients suspected of transient ischaemic attack in primary care: A diagnostic accuracy study |
| المؤلفون: |
Dolmans, Louis Servaas, Rutten, Frans, Bartelink, Marie Louise E.L., Van Dijk, Ewoud J., Nederkoorn, Paul J., Kappelle, Jaap, Hoes, Arno W. |
| المساهمون: |
HAG Hart- Vaatziekten, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Huisartsopleiding, JC Overig onderzoek, Public Health Practice, ZL Cerebrovasculaire Ziekten Medisch, Brain, Directie Raad van Bestuur, General Practice & Nursing Science |
| سنة النشر: |
2019 |
| مصطلحات موضوعية: |
biomarker, diagnostic accuracy, minor stroke, panel, TIA, General Medicine, Journal Article |
| الوصف: |
Objective The diagnosis of transient ischaemic attack (TIA) based on symptoms and signs can be challenging and would greatly benefit from a rapid serum biomarker of brain ischaemia. We aimed to quantify the added diagnostic value of serum biomarkers in patients suspected of TIA beyond symptoms and signs. Methods This is a cross-sectional diagnostic accuracy study with a 6-month follow-up period. Participants were patients suspected of TIA by the general practitioner (GP) in whom a blood sample could be collected within 72 hours from symptom onset. A research nurse visited the participant for the blood sample and a standardised interview. The GP referred participants to the regional TIA service. An expert panel of three neurologists classified cases as TIA, minor stroke or any other diagnosis, based on all available diagnostic information including the GP's and neurologist's correspondence and the follow-up period. We used multivariable logistic regression analyses to quantify the diagnostic accuracy of clinical predictors and the improvement of accuracy by seven biomarkers (NR2, NR2 antibodies, PARK7, NDKA, UFD1, B-FABP and H-FABP). Results 206 patients suspected of TIA participated, of whom 126 (61.2%) were diagnosed with TIA (n=104) or minor stroke (n=22) by the expert panel. The median time from symptom onset to the blood sample collection was 48.0 (IQR 28.3-56.8) hours. None of the seven biomarkers had discriminative value in the diagnosis of TIA, with C-statistics ranging from 0.45 to 0.58. The final multivariable model (C-statistic 0.83 (0.78-0.89)) consisted of eight clinical predictors of TIA/minor stroke: increasing age, a history of coronary artery disease, sudden onset of symptoms, occurrence of symptoms in full intensity, dysarthria, no history of migraine, absence of loss of consciousness and absence of headache. Addition of the individual biomarkers did not further increase the C-statistics. Conclusions Currently available blood biomarkers have no added diagnostic value in suspected TIA. Trial ... |
| نوع الوثيقة: |
article in journal/newspaper |
| وصف الملف: |
image/pdf |
| اللغة: |
English |
| تدمد: |
2044-6055 |
| العلاقة: |
https://dspace.library.uu.nl/handle/1874/389262Test |
| الإتاحة: |
https://dspace.library.uu.nl/handle/1874/389262Test |
| حقوق: |
info:eu-repo/semantics/OpenAccess |
| رقم الانضمام: |
edsbas.D2E44A55 |
| قاعدة البيانات: |
BASE |
Full Text Finder